WV Cannabis Tax Structure — 10% Privilege Tax (W. Va. Code § 16A-9-1)

Last verified: May 2026

The 10% Privilege Tax — What It Is and Isn’t

Older guides to West Virginia medical cannabis sometimes describe the program as carrying a "10% cultivator excise plus 6% sales tax." That is incorrect. Under W. Va. Code § 16A-9-1, the actual structure is a single layer:

• 10% privilege tax on the gross receipts of dispensaries from the sale of medical cannabis to patients or caregivers
• Paid by the dispensary — not added as a line item on the patient receipt
• Not collected at the cultivator/processor level (no separate excise)

The privilege tax is economically passed through to patient pricing — a $50 vape cartridge implicitly includes the dispensary’s $5 tax obligation — but legally it is a tax on the dispensary’s commercial activity, not a consumer sales tax.

The 6% Sales-Tax Exemption

West Virginia’s general 6% state consumer sales-and-use tax under W. Va. Code § 11-15-1 et seq. does not apply to medical cannabis. Medical cannabis is also exempt from any local sales taxes. This makes WV one of relatively few medical states where medical cannabis prices are NOT layered with the standard consumer sales tax. (Adult-use programs in surrounding states — Maryland 9%, Ohio 10% adult-use excise, etc. — do layer multiple taxes; West Virginia’s medical tax burden is comparatively simple.)

Where the Money Goes — The Fund Allocation

Of the privilege-tax revenue deposited in the West Virginia Medical Cannabis Program Fund, statute directs:

• 55% to the Bureau for Public Health — supports OMC operations, regulatory functions, METRC enforcement, inspections, and lab oversight
• Of the remaining 45%:
  • 50% to the Fight Substance Abuse Fund — supports treatment, recovery, and harm-reduction programs (~22.5% of total)
  • 40% to the Division of Justice and Community Services — grants to local law enforcement (~18% of total)
  • 10% for law-enforcement professional training (~4.5% of total)

The allocation reflects the legislative compromise behind SB 386: program revenue must support public-health and law-enforcement priorities, not just cannabis program operations. This is the funding pattern that produced the political support needed to pass the bill in 2017 over Senate President Bill Cole and House Speaker Tim Armstead’s opposition.

~$38M Cumulative Tax Collected (March 2026)

Per West Virginia Treasurer Larry Pack’s March 2026 statement to The Dominion Post, the state had collected approximately $38 million in privilege-tax revenue since program launch in November 2021. With cumulative sales now exceeding $300 million as of spring 2026, the 10% rate yields roughly $30M+ in tax to date, with additional miscellaneous revenue making up the balance.

For most of the program’s early years, the cumulative fund was held essentially unspent — the federal Schedule I status of cannabis prevented the state from confidently disbursing the funds without provoking federal questions. After President Trump’s December 18, 2025 executive order directing federal agencies to expedite Schedule III rescheduling, and the DOJ’s April 28, 2026 Schedule III rescheduling order (91 Fed. Reg. 22714), the path to disbursement opened. Treasurer Pack announced his office would begin disbursing the funds in April 2026.

HB 5074 (2026) and the Morrisey Veto

The 2026 West Virginia Legislature passed HB 5074, sponsored by Del. Evan Worrell (R-Cabell), which would have reallocated the accumulated ~$38M Medical Cannabis Program Fund toward:

• Homelessness services
• Child welfare
• University research

Gov. Patrick Morrisey vetoed HB 5074, citing concerns that the bill "pre-committed future revenue streams" and risked tying the state’s hands on opioid-recovery and public-health priorities. Treasurer Pack proceeded to allocate the funds in April 2026 under his interpretation of statutory authority — setting up an unresolved executive-branch / treasurer-office tension that may revisit the Legislature in 2027.

The HB 5074 fight is a useful illustration of how cannabis program revenue has become entangled with broader West Virginia fiscal politics. See Morrisey opposition page.

Why the Tax Structure Matters Politically

The single-layer 10% privilege tax has shaped WV cannabis politics in three ways:

• Lower retail prices than full-stack states — WV medical product is generally cheaper than equivalent product in jurisdictions that layer 10-25% sales taxes plus excise taxes. (Operating costs and statutory caps offset some of this advantage.)
• Predictable revenue formula — 10% of dispensary gross receipts is straightforward to forecast, audit, and remit. Unlike states with weight-based excise taxes, WV does not need to track THC content or grams sold to compute tax.
• Public-health framing — the 50% Fight Substance Abuse / 40% local law enforcement / 10% police training allocation reads like an opioid-recovery package. That was deliberate: SB 386’s political path required pairing cannabis revenue with anti-substance-abuse spending.

Federal Tax (IRC § 280E)

While West Virginia’s state-tax structure is relatively favorable, federal taxation under Internal Revenue Code § 280E remains punishing for WV cannabis operators. Section 280E disallows ordinary business deductions for any business "trafficking" in a Schedule I substance — meaning a WV dispensary cannot deduct rent, employee wages outside of cost-of-goods-sold, security, advertising, or other typical business expenses for federal income-tax purposes. Effective federal tax rates for cannabis operators routinely exceed 60-70% of net income.

The April 28, 2026 DOJ Schedule III rescheduling order (91 Fed. Reg. 22714) does not by itself remove § 280E exposure for cannabis businesses; further administrative or legislative action is required, and the IRS has not yet published guidance on how rescheduling affects § 280E enforcement. As of May 2026, WV operators continue to plan for § 280E exposure.

Comparison to Adult-Use Neighbors

• Maryland adult-use: 9% sales tax on adult-use cannabis (medical exempt); plus dispensary licensing fees. The 9% rate is lower than many adult-use states.
• Ohio adult-use: 10% adult-use excise tax + 5.75% state sales tax (medical exempt).
• Pennsylvania medical: 5% grower-processor tax (NOT a consumer sales tax); medical exempt from PA’s 6% sales tax.
• West Virginia medical: 10% dispensary privilege tax; no separate excise, no sales tax, no grower tax.

If West Virginia ever moves to adult-use, the natural template is a layered structure (privilege + excise + sales) similar to Ohio or Maryland. With Gov. Morrisey opposed and the Senate firewall under President Smith, that move is not on the near-term horizon.

Related on this site: WV 30-Day Supply Limit, The WV Four-Year Delay, How to Get a West Virginia Medical Ca....